Industry News

News Powered By:

- a collaborative partner.


 


Cancer Research U.K. to launch 14-drug, personalized medicine trial


CenterWatch News Online Headlines : April 18, 2014 8:57 am : Centerwatch

British researchers, working with two global pharmaceutical companies, are planning to launch a different kind of personalized medicine clinical trial that could change how cancer drugs are studied and potentially cut the time and cost of bringing them to market.



Report: Biomarker market for diagnostic applications to reach $30.6B globally by 2020


CenterWatch News Online Headlines : April 18, 2014 7:40 am : Centerwatch

According to a new report from Allied Market Research, the global biomarkers market for diagnostic applications such as risk assessment, molecular diagnostic, disease diagnosis, drug discovery and development, drug formulation, forensic and other such applications is set to reach about $30.6 billion in 2020, growing at CAGR of 16% from 2013 to 2020.



AMRI shutters New York research center, cuts 45 jobs


CenterWatch News Online Headlines : April 18, 2014 7:39 am : Centerwatch

Albany Molecular Research (AMRI), a global contract research and manufacturing organization, will be transitioning Discovery and Development Services (DDS) activities at its Syracuse, N.Y., site to other sites within AMRI and will cease operations in Syracuse by the end of June.



SMART Platforms Project names advisory committee


CenterWatch News Online Headlines : April 18, 2014 6:26 am : Centerwatch

The SMART (Substitutable Medical Apps & Reusable Technology) Platforms project at Boston Children’s Hospital—which is developing technology to create an app-driven health information economy—has announced the formation of an advisory committee that will guide the project on strategy, technical approach and business development.



First patient enrolled in Boston Scientific’s new clinical registry


CenterWatch News Online Headlines : April 18, 2014 5:43 am : Centerwatch

Boston Scientific has enrolled the first patient in a new registry to evaluate clinical outcomes and the economic value of the Vercise Deep Brain Stimulation (DBS) System in patients with Parkinson’s disease (PD).


« Page 1, 2, 3273 »